It seems Paul Tange was right about one thing, it's not the individual that innovate take credit to the accomplishments; it's the company and their leaders instead. That's why no news being heard with a Japanese small enterprise that grows up unlike in the US or Indonesia. Correct me if I'm wrong. Japanese doesn't want migration. They exercise such hypocrisy on tourism. They are courting millionaires that spend less. There are lots of market and sectors Japan can tap on for growth. Maybe it's time to practice openness like in the Meiji Era.
What do you think about investing in Japanese pharmaceutical companies? With aging population and the wealth distribution overwhelmingly skewed towards older people, pharma seems like a growth sector? For example Eisai, they make Lecanemab for Alzheimer's? Or do you think it would be better to spread it across the largest companies in the sector? Eisai, Daiichi Sankyo, Takeda, Astellas, Chugai, Otsuka, etc. All of them look like really good companies making world leading products.
You're right that Japan’s aging population makes pharma a tempting sector, but much of that growth is already priced in. Companies like Takeda (P/E > 45) are quite overvalued, in my opinion. However, there are still some solid, overlooked opportunities, perhaps for good reason, companies like Kowa (P/E ~6x) or Suzuken (~13x), which are trading at much better valuations.
@@konichivalue I looked at Kowa (7807). I can't understand it. Their website is unhelpful. It's impossible for foreigners to understand this. Takeda, Eisai, Daiichi are very expensive, but they have close collaborations with western companies and their products are sold in the west. There is a lot of interest in investing in Japan, but the only companies that foreigners can understand are companies like Eisai (4523) because they make the Alzheimer dug in collaboration with Biogen. Then Eisai has P/E of 45, while Biogen has P/E of 23, so then it is as you say these Japanese stocks are overpriced. It would be great if you can do a series talking about Japanese companies that foreigners don't know about. Especially ones with great products that are widely used in Japan but not used much abroad.
Yes, Japanese trading companies like Itochu, Mitsubishi, Sojitz, Marubeni etc. Gives you a big exposure to the Japanese market while still often being undervalued compared to the assets they hold
Nice, thanks!
Ok the nikkei set a new high since 1989 but if you adjust for inflation it's still veeeery low.
To be fair, there's not been much inflation
Japan has had almost no inflation since 1989
@@konichivalue that's right.
Thank you for your content 🎉 much respect from Kyoto Gion
It seems Paul Tange was right about one thing, it's not the individual that innovate take credit to the accomplishments; it's the company and their leaders instead. That's why no news being heard with a Japanese small enterprise that grows up unlike in the US or Indonesia. Correct me if I'm wrong.
Japanese doesn't want migration. They exercise such hypocrisy on tourism. They are courting millionaires that spend less. There are lots of market and sectors Japan can tap on for growth. Maybe it's time to practice openness like in the Meiji Era.
Thought this video was going to be about the price of goods and tourism 😅
Sorry to disappoint you 🥺
What do you think about investing in Japanese pharmaceutical companies? With aging population and the wealth distribution overwhelmingly skewed towards older people, pharma seems like a growth sector? For example Eisai, they make Lecanemab for Alzheimer's? Or do you think it would be better to spread it across the largest companies in the sector? Eisai, Daiichi Sankyo, Takeda, Astellas, Chugai, Otsuka, etc. All of them look like really good companies making world leading products.
You're right that Japan’s aging population makes pharma a tempting sector, but much of that growth is already priced in. Companies like Takeda (P/E > 45) are quite overvalued, in my opinion. However, there are still some solid, overlooked opportunities, perhaps for good reason, companies like Kowa (P/E ~6x) or Suzuken (~13x), which are trading at much better valuations.
@@konichivalue I looked at Kowa (7807). I can't understand it. Their website is unhelpful. It's impossible for foreigners to understand this. Takeda, Eisai, Daiichi are very expensive, but they have close collaborations with western companies and their products are sold in the west. There is a lot of interest in investing in Japan, but the only companies that foreigners can understand are companies like Eisai (4523) because they make the Alzheimer dug in collaboration with Biogen. Then Eisai has P/E of 45, while Biogen has P/E of 23, so then it is as you say these Japanese stocks are overpriced. It would be great if you can do a series talking about Japanese companies that foreigners don't know about. Especially ones with great products that are widely used in Japan but not used much abroad.
would you recommend someone who has never invested before in anything to invest in japanese stocks?
Yes, Japanese trading companies like Itochu, Mitsubishi, Sojitz, Marubeni etc. Gives you a big exposure to the Japanese market while still often being undervalued compared to the assets they hold
Hi
Great video. Where do you have your money invested? 😅
A lot in Sega Sammy, Nintendo, Itochu and Mizuno :)